ABT-614

DRUG3 trials

Sponsors

Abbott

Conditions

HealthyHealthy VolunteersType 2 Diabetics, Chronic Kidney Disease, Protein in Urine

Phase 1

Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain

CompletedNCT00788801

AbbottHealthy Volunteers

Start: 2008-12-31Updated: 2010-11-02

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

CompletedNCT00959816

Start: 2009-08-31Updated: 2010-11-02

A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

CompletedNCT01464320

AbbottType 2 Diabetics, Chronic Kidney Disease, Protein in Urine

Start: 2011-11-30End: 2012-04-30Updated: 2012-08-22